Zhang Dengshen, Cao Yiran, Liu Daxing, Zhang Jian, Guo Yingqiang
Department of Cardiovascular Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China.
Front Cardiovasc Med. 2022 Jul 28;9:935054. doi: 10.3389/fcvm.2022.935054. eCollection 2022.
Mounting evidence suggests that the phenotypic transformation of venous smooth muscle cells (SMCs) from differentiated (contractile) to dedifferentiated (proliferative and migratory) phenotypes causes excessive proliferation and further migration to the intima leading to intimal hyperplasia, which represents one of the key pathophysiological mechanisms of vein graft restenosis. In recent years, numerous miRNAs have been identified as specific phenotypic regulators of vascular SMCs (VSMCs), which play a vital role in intimal hyperplasia in vein grafts. The review sought to provide a comprehensive overview of the etiology of intimal hyperplasia, factors affecting the phenotypic transformation of VSMCs in vein graft, and molecular mechanisms of miRNAs involved in SMCs phenotypic modulation in intimal hyperplasia of vein graft reported in recent years.
越来越多的证据表明,静脉平滑肌细胞(SMC)从分化型(收缩型)向去分化型(增殖型和迁移型)表型的转变会导致过度增殖,并进一步向内膜迁移,从而导致内膜增生,这是静脉移植物再狭窄的关键病理生理机制之一。近年来,大量的微小RNA(miRNA)已被鉴定为血管平滑肌细胞(VSMC)的特定表型调节因子,它们在静脉移植物的内膜增生中起着至关重要的作用。这篇综述旨在全面概述内膜增生的病因、影响静脉移植物中VSMC表型转变的因素,以及近年来报道的miRNA参与静脉移植物内膜增生中SMC表型调节的分子机制。